VICPOTCPharmaceutical PreparationsFiscal year ends December 31
Vicapsys Life Sciences, Inc.
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Jan 10, 2025
$0.40+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $13.73M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.3700 (−77.40%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Sep 30, 2024
Valuation
- Market cap
- $13.73M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$1.35M
- EPS, diluted
- -$0.05
- Book value per share
- -$0.08
- Diluted shares
- 34M
Six years at a glance
Fiscal years 2018 to 2023 and trailing twelve months, USD
Operating income
-$1.11M
Net income
-$1.35M
EPS, diluted
-$0.05
Reported periodTrailing twelve months